Sobre Epredia - The PHC Group
Epredia, established in July 2019 through an acquisition by PHC Group from Thermo Fisher Scientific, is a global precision cancer diagnostics company working to improve patient outcomes by providing groundbreaking technologies. Powered by trusted brands such as Shandon, Microm, Menzel Gläser and Richard-Allan Scientific, Epredia has a wide breadth of solutions that are transforming the anatomical pathology market.



